Equities

Spero Therapeutics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Spero Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.36
  • Today's Change-0.06 / -2.48%
  • Shares traded349.23k
  • 1 Year change+188.37%
  • Beta1.4413
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Monday, Spero Therapeutics Inc (SPRO:NSQ) closed at 2.36, -26.71% below its 52-week high of 3.22, set on Jul 09, 2025.
52-week range
Today
0.5052Apr 09 20253.22Jul 09 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open2.40
High2.40
Low2.28
Bid2.27
Offer2.30
Previous close2.42
Average volume480.86k
Shares outstanding56.34m
Free float43.42m
P/E (TTM)--
Market cap136.34m USD
EPS (TTM)-0.7949
USD
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼

Events & Activity

  • SPRO:NSQ trading volume exceeds daily average by +74.89%
  • SPRO:NSQ price falls below 50-day moving average to 2.35 at 14:37 GMT
  • SPRO:NSQ price moved over +6.55% to 2.44
  • SPRO:NSQ price rises above 50-day moving average to 2.35 at 14:38 GMT
  • SPRO:NSQ price rises above 50-day moving average to 2.36 at 14:40 GMT
  • SPRO:NSQ price falls below 15-day moving average to 2.31 at 14:37 GMT
  • SPRO:NSQ price rises above 15-day moving average to 2.33 at 14:34 GMT
  • SPRO:NSQ price rises above 15-day moving average to 2.34 at 14:40 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.